Welcome back to Health Unlocked! In this episode, Jasen Petersen takes us deep into the world of medical devices, regulatory pathways, and the bold vision for the IBAL platform. Jasen Petersen breaks down the crucial differences between drugs and devices; why it matters for innovation, safety, and getting new therapies to patients faster.

You'll hear firsthand about IBAL’s journey through regulatory approval in Mexico and the UAE, how previous groundwork helps set the stage for U.S. expansion, and the strategic thinking behind choosing the right device pathway. Jasen also tackles the complexities of claims, regulations, and evidence, explaining why language, transparency, and governance are make-or-break factors. He explores how new funding and governance models like Decentralized Science (DeSci) and DAOs can unlock ingenuity and integrity, helping promising therapies break out of the traditional pharma mold.

If you’re curious about the future of medical innovation, how “terrain-aligned” approaches challenge the status quo, or just want an inside look at the regulatory chess game behind breakthrough products, this is an episode you don’t want to miss!

Timestamps:

00:00 Drug Development vs. FDA Standards

04:45 "Medical Device Approval Simplified"

08:43 FDA Evaluation and Approval Process

12:25 "Why Supplements Aren't Regulated Drugs"

13:38 Pharma Challenges: Funding, Claims, Safety

19:16 "IBAL's Potential Across Indications"

23:07 Transparent Governance Ensures Accountability

24:02 "Mission-Driven Decision Making"

29:15 "Ion Gel Healing and Data"

31:36 "Paradigm Shifts and Awareness"

33:30 "Ion Gel: Transparent Evidence"

“Disclaimer: Informational only. Not medical advice. Consult your doctor for guidance.”

Show Website - https://powerofsalutogenesis.com/

Ionic Alliance Foundation Website - https://iaf.care/

Jasen Petersen's LinkedIn - https://www.linkedin.com/in/jasenepetersen/

TopHealth Media Website - https://tophealth.care/